Stock listing

Genfit Sa

Selected listing: GNFT · EURONEXT · EUR · FR

Genfit Sa (Euronext:GNFT), Health Technology. Latest release Sep 29, 2026: GENFIT : Reports First-Half 2026 Financial Results and Provides Corporate Update.

GNFT:EURONEXTEURFRUpdated October 3, 2026

Ticker: Euronext:GNFT
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Euronext
Currency: EUR

About Genfit Sa

Genfit SA is a public company based in France, trading under the ticker GNFT. Genfit focuses on developing innovative solutions for metabolic and liver diseases.

Latest news from Genfit Sa

GENFIT : Reports First-Half 2026 Financial Results and Provides Corporate Update

September 29, 2026

GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update

September 28, 2026

GENFIT : Résultats financiers du premier semestre 2026 et point sur les activités de la Société

September 27, 2026

GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF

September 14, 2026

GENFIT engage un programme de développement clinique de phase 2 avec Nangibotide dans l’ACLF

September 13, 2026

All Genfit Sa news →

Research Genfit Sa

Genfit Sa company profile

View the public company page for Genfit Sa on 6ix.

Genfit Sa news

Read company news and market updates connected to Genfit Sa.

Genfit Sa investor events

Find investor webinars, events, and replay context for Genfit Sa.